Related Experiment Video
Updated: Jun 18, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy
Shiro Nakamori1, Ethan J Rowin2, Jennifer Rodriguez3
1Departments of Medicine (Cardiovascular Division) Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA; Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
Insights
Younger hypertrophic cardiomyopathy (HCM) patients show faster late gadolinium enhancement (LGE) progression than older adults. This highlights the need for regular cardiovascular magnetic resonance (CMR) monitoring in younger HCM individuals to track fibrosis development.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Medical Research
Background:
- Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) indicates increased sudden cardiac death risk in hypertrophic cardiomyopathy (HCM).
- Longitudinal changes in LGE extent and their association with age are not well understood in HCM patients.
- Assessing age-specific LGE progression is crucial for risk stratification in HCM.
Purpose of the Study:
- To investigate age-specific differences in the progression of late gadolinium enhancement (LGE) in hypertrophic cardiomyopathy (HCM).
- To compare LGE progression rates between young to middle-aged adults (20-59 years) and older adults (≥60 years) with HCM.
Main Methods:
- Retrospective analysis of 102 HCM patients with serial CMR studies over a median of 3.7 years.
- Semiautomated quantification of LGE extent relative to left ventricular (LV) mass.
- Comparison of LGE progression rates between age groups (<60 years and ≥60 years).
Main Results:
- LGE was present at baseline in 60% of HCM patients, averaging 4.8% of LV mass.
- At follow-up, 87% of patients with baseline LGE showed an increase, reaching 7.7% of LV mass.
- Patients under 60 years had a significantly higher rate of LGE progression (≥1%/year) compared to those 60 and older (25% vs. 7%, p=0.03).
Conclusions:
- Progressive fibrosis, indicated by LGE, is more common in younger to middle-aged adults with HCM.
- Younger age (<60 years) and baseline LGE extent (≥10%) are predictors of accelerated LGE progression.
- Serial CMR is important for monitoring LGE progression in younger HCM patients.
Background:
The extent of late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) in patients with hypertrophic cardiomyopathy (HCM) is associated with an increased risk of sudden cardiac death events. However, the clinical significance of age-specific longitudinal changes in LGE is not well characterized in HCM. We sought to assess whether the risk of LGE progression diverges between young to middle-aged (ages 20-59 years) and older (≥ 60) adults with HCM.
Methods:
A total of 102 HCM patients (age <60 years; n=75, age ≥60 years; n=27) undergoing serial CMR studies from two tertiary medical centers were evaluated. The median time interval between initial and follow-up CMR scans was 3.7 years. LGE was semiautomatically quantified by measuring regions with signal intensity >6 SD above the nulled remote myocardium and manually adjusting a grayscale threshold.
Results:
LGE was identified at baseline in 61 of the 102 HCM patients (60%), occupying 4.8 ± 3.9% of the left ventricular (LV) mass. At the end of the follow-up period, 53 of the 61 patients (87%) demonstrated an increase in the extent of LGE to 7.7 ± 5.4%, and 8 patients had no change. In 5 patients (5%), LGE increased to extensive with >15% of the LV mass. The rate of LGE progression was 0.7 ± 1.0%/year, including 21 patients (21%) with particularly accelerated progression of ≥1%/year. The risk of LGE progression ≥1%/year was significantly higher in patients <60 years than those ≥ 60 years (25% vs. 7%, p=0.03). The odds of LGE progression ≥1%/year was almost 4 times greater for patients <60 years compared with those ≥ 60 years (odds ratio, 4.2; 95%CI, 1.1-27.9). Age <60 years and LGE extent ≥ 10% were significant baseline predictors for future LGE progression ≥1%/year, even after adjustment for other potential risk factors.
Conclusion:
In HCM, progressive fibrosis occurs more frequently in young to middle-aged patients, underscoring the importance of repeating CMR to re-evaluate for potential LGE progression in this age group.
More Related Videos
07:10Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
Published on: May 16, 2021
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...